Skip to content
The Policy VaultThe Policy Vault

Tyenne subcutaneous — Medica

All other conditions including systemic juvenile idiopathic arthritis

Initial criteria

  • Patient meets the standard Inflammatory Conditions – Tocilizumab Subcutaneous Prior Authorization Policy criteria

Approval duration

1 year